Primary Care Clinics in Eagan, MN Accepting Medicare
26 Primary Care Clinics found. Showing 21 - 26
 Hy-vee Health Pc Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1500 Central Park Commons Dr, Eagan, MN 55121 Phone: 515-225-2930 Fax: 515-559-2495 |
Allina Health Eagan Clinic Family Medicine Medicare: Medicare Enrolled Practice Location: 1110 Yankee Doodle Rd, Eagan, MN 55121 Phone: 651-454-3970 Fax: 651-241-0059 |
Online Care Clinic/Center - Multi-Specialty Medicare: Not Enrolled in Medicare Practice Location: 3535 Blue Cross Rd, Eagan, MN 55122 Phone: 651-662-4666 Fax: 651-662-4666 |
Minnesota Neurodiagnostics, Llc Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 860 Blue Gentian Rd, Ste. 200 Office 203, Eagan, MN 55121 Phone: 469-995-8416 Fax: 866-279-4704 |
Evergreen Primary Care Pllc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1337 Wilderness Run Dr, Eagan, MN 55123 Phone: 612-817-7240 |
Helping Hands Chiropractic Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 4660 Slater Rd, Suite 140, Eagan, MN 55122 Phone: 651-452-3900 |
News Archive
Cosmetic makers harness microbiome to help treat skin conditions
Cosmetic companies have started developing and selling products designed to harness the skin microbiome to help treat a range of skin conditions from acne to eczema.
Belatacept costimulation blocker can prevent rejection of new organs by the immune system
Initial results of a study conducted at 100 centers worldwide indicate that belatacept, a first-in-class costimulation blocker can prevent the immune system rejecting new organs. The results also suggest that it may provide similar patient and graft survival to cyclosporine but with fewer side effects and superior kidney function after 12 months. The study, published today in the American Journal of Transplantation, provides the first findings to come from BENEFIT (Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial).
Cuddles diminishes pain from heel lance in preterm babies
Research published today in the open access journal BMC Pediatrics suggests that very preterm babies, born between 28 and 31 weeks, could benefit from skin-to-skin cuddling with their mother before and during painful procedures such as a heel lance.
Study sheds light on neuronal circuits during risky behavior
New research sheds light on what's going on inside our heads as we decide whether to take a risk or play it safe. Scientists at Washington University School of Medicine in St. Louis located a region of the brain involved in decisions made under conditions of uncertainty, and identified some of the cells involved in the decision-making process.
Merck-Chimie to commercialize CardioGenics' proprietary paramagnetic beads
CardioGenics Holdings Inc., developer of the ultra-sensitive QL Care™ Point-Of-Care (POC) analyzer and products for the immunoassay segment of the In-Vitro Diagnostics market, announced that CardioGenics Inc. and Merck Chimie S.A.S. have agreed on a plan to commercialize CardioGenics' proprietary paramagnetic beads, with shipments to Merck-Chimie's customers scheduled to start mid-September 2010.
› Verified 8 days ago
- 1
- 2(current)